supp.fit

Zeaxanthin and Vitamin E: study protocols

7 study groups took Zeaxanthin together with Vitamin E. These are the doses the studies gave. They are not a recommendation.

Zeaxanthin: what the research found →

Dose per serving from research: Zeaxanthin

7 study groups in 6 studies say how much Zeaxanthin participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 1 mg to 2.5 mg, 71% of 7 study groups.

Daily doseStudy groups
500 mcg to 1 mg
2
1 mg to 2.5 mg
5

Commonly used together

7 of 7 study groups took Zeaxanthin and Vitamin E with something else. Shown: what 3 or more different studies gave.

What was given together, not what works together.

Taken withStudy groups
Lutein
7
Vitamin C
5
Zinc
5

7 study groups

Study
Omega-3 fatty acid, carotenoid and vitamin E supplementation improves working memory in older adults: A randomised clinical trial
2022 · active group · Cognitively healthy adults aged 65 years and older
2 mg15 mg2 years30
Visual Function and Macular Carotenoid Changes in Eyes with Retinal Drusen-An Open Label Randomized Controlled Trial to Compare a Micronized Lipid-Based Carotenoid Liquid Supplementation and AREDS-2 Formula
2020 · PV group · Adults aged 54–80 with retinal drusen and risk of age-related macular degeneration
2 mg—26 weeks20
Carotenoids and antioxidants in age-related maculopathy italian study: multifocal electroretinogram modifications after 1 year
2008 · treated AMD (T-AMD) group · Patients with nonadvanced age-related macular degeneration; mean age 69.4 years
1 mg30 mg1 year15
Beneficial Effects of Micronutrient Supplementation in Restoring the Altered Microbiota and Gut-Retina Axis in Patients with Neovascular Age-Related Macular Degeneration-A Randomized Clinical Trial
2024 · intervention group · Adults with neovascular age-related macular degeneration; mean age 77.8 years
2 mg12 mg26 weeks15
Supplementation With Carotenoids, Omega-3 Fatty Acids, and Vitamin E Has a Positive Effect on the Symptoms and Progression of Alzheimer's Disease
2022 · active group · People with mild-moderate Alzheimer's disease; age and sex not reported
2 mg15 mg1 year50
Long term effects of lutein, zeaxanthin and omega-3-LCPUFAs supplementation on optical density of macular pigment in AMD patients: the LUTEGA study
2013 · D2 (twice daily) · Patients with non-exudative age-related macular degeneration; age and sex not specified
2 mg—1 year55
Long term effects of lutein, zeaxanthin and omega-3-LCPUFAs supplementation on optical density of macular pigment in AMD patients: the LUTEGA study
2013 · D1 (once daily) · Patients with non-exudative age-related macular degeneration; age and sex not specified
1 mg—1 year50
Zeaxanthin and Vitamin E: study protocols | supp.fit